IMA as of Nov 4 · 14:39 ET
IMANasdaqBiological Products, (No Diagnostic Substances)

ImageneBio, Inc. · Brief

Next report

7 days

Nov 11 · before openest.Q3 FY26

Expected move

No implied move.

Implied vs realized

1 reportHistory
—≥ implied
Q2 FY26—▲+0.70%—
quarterimplied−5%0+5%realized×
Q2 FY26—▲+0.70%—
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 11 report · est.

Bull2 of 3

3disclosed supplier and customer ties with established industry counterpartiesSEC filings
36managers reporting a position across institutional investor portfolios13F · Jun 30 '26

Bear2

8managers holding most of the reported value among reporting holders13F · Jun 30 '26
8 of 21a portion of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Oct 26 '26once per report · top 2 per case

Linked exposure

IMA report session

No linked exposure.

Latest changes

30 daysAll changes

No changes.

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.